HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- ‘Tide has turned’ in AML: Better understanding of disease biology may lead to treatment advances
-
- Studies review updates in mammography, mastectomy and margin width Anees B. Chagpar, MD
- Three keys to value from patient’s perspective: time, communication, education Lindsey E. Sirianno, MSPAS, PA-C
- ASTRO names inaugural members of health policy fellowship program
- Fred Hutchinson Cancer Research Center hires executive vice president
- Henry Ford Health System program director named Komen Scholar
- NCI grant to fund AML research at City of Hope
- Oncology Nursing Society presents award to AACR CEO
- Vanderbilt University Medical Center names executive vice president for research
-
- Gynecologic Cancer Drugs in the Pipeline
- It’s good to share, both in research and in life John Sweetenham, MD, FRCP, FACP
- FDA approves first blood test for colorectal cancer
- FDA approves Lenvima for advanced renal cell carcinoma
- FDA grants fast track designation to ADXS-HER2 for osteosarcoma
- FDA grants priority review to Blincyto to treat pediatric B-cell precursor ALL
- FDA grants priority review to olaratumab for soft tissue sarcoma
- FDA extends authority over e-cigarettes, cigars, hookah tobacco Michael B. Steinberg, MD, MPH, FACP
-
- Addition of ultrasound to mammography improves breast cancer detection
- Advanced ovarian clear cell carcinoma increases risk for VTE
- Biomarker expression may predict CNS relapse risk in DLBCL
- Dendritic cell vaccination, antiestrogen therapy boosts pathologic complete response in breast cancer
- Erlotinib beyond progression may delay salvage therapy in EGFR-mutated NSCLC
- High-dose cyclophosphamide reduces incidence of GVHD following stem cell transplant
- Initiation of palliative care in ED improves quality of life
- Initiative to ‘avoid heparin’ reduces heparin-induced thrombocytopenia, costs
-
- LMWH does not improve pregnancy outcomes for women with thrombophilia, prior miscarriages
- Modified chemotherapy regimen effective, less toxic for gastric cancers
- Monthly cost of oral cancer drugs rises steadily over time
- New-generation TKIs for CML increase risk for cardiovascular events
- Oncology community questions proposed changes to Medicare Part B reimbursement
- Pain control a necessary component of cancer treatment
- Radiation reduces failure risk in newly diagnosed nonmetastatic prostate cancer
- Report outlines research goals, knowledge gaps in ovarian cancer
-
- Response to therapy assessment effective for dynamic risk stratification in thyroid cancer
- Twins demonstrate significant excess familial risk for cancer
- Accelerated partial-breast irradiation confers similar toxicity, cosmetic results as whole-breast irradiation
- AUA antibiotic prophylaxis guidelines reduce infectious complications from prostate biopsy
- Breast-conserving therapy may increase local recurrence risk in younger women
- CD4 T-cell immunotherapy that targets MAGE-A3 shows promise in metastatic cancer
- Delays in radiation receipt for DCIS associated with increased ipsilateral tumor risk
- Ibrutinib dose adherence associated with higher PFS for CLL
-
- Less aggressive DCIS treatment increases risk for recurrence
- Location of primary tumor predicts colorectal cancer survival outcomes
- LOXO-101 shows promise for solid tumors with NTRK gene fusions
- Many women qualify for breast cancer screening before recommended age
- Neoadjuvant ado-trastuzumab emtansine, pertuzumab increases pathologic complete response in HER-2–positive breast cancer
- Nipple-sparing mastectomy reduces breast cancer risk for BRCA–positive women
- Nivolumab demonstrates efficacy in recurrent, metastatic SCCHN
- Nivolumab increases 5-year survival in metastatic melanoma
-
- Pembrolizumab improves long-term outcomes for patients with advanced melanoma
- Pembrolizumab induces durable responses in advanced Merkel cell carcinoma
- SBRT may increase risk for noncancer death in patients with NSCLC